Enzymotec Ltd. Reports First Quarter 2017 Unaudited Financial Results
May 17, 2017 11:31 am UTC| Business
MIGDAL HAEMEQ, Israel, May 17, 2017 -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today reported financial results for the first...
Enzymotec Ltd. Reports First Quarter 2017 Unaudited Financial Results
May 17, 2017 11:31 am UTC| Business
MIGDAL HAEMEQ, Israel, May 17, 2017 -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today reported financial results for the first...
May 17, 2017 11:31 am UTC| Business
TowerJazz, the global specialty foundry leader, today announced details on its 12th annual Technical Global Symposium (TGS) being held in Europe, Japan, Korea, and the United States. This year, TowerJazz’s TGS series will...
May 17, 2017 11:31 am UTC| Business
TowerJazz, the global specialty foundry leader, today announced details on its 12th annual Technical Global Symposium (TGS) being held in Europe, Japan, Korea, and the United States. This year, TowerJazz’s TGS series will...
Comview Embarks on AOTMP Efficiency First® Solution Re-Certification Process
May 17, 2017 11:30 am UTC| Business
INDIANAPOLIS, May 17, 2017 -- AOTMP is pleased to announce that Comview is recertifying its communication lifecycle solutions in AOTMP’s Efficiency First® Vendor Solution Certification Program. As part of the...
Evogene Reports First Quarter 2017 Financial Results
May 17, 2017 11:04 am UTC| Business
REHOVOT, Israel, May 17, 2017 -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading company for the improvement of crop productivity and economics for food, feed and fuel, announced today its financial results for the...
ProQR Announces Results for the First Quarter of 2017
May 17, 2017 11:03 am UTC| Business
Key updates QR-010 Phase 1b clinical trial on track to present top-line data in cystic fibrosis (CF) patients in mid-2017.Investigational new drug (IND) application for QR-110, ProQR’s lead program in ophthalmology, was...